Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Exact Sciences

Request full access

Developer and manufacturer of cologuard, a non-invasive screening test for the early detection of colorectal cancer

Madison, United StatesFounded 1995Biotech & Life Sciences

At a glance

Status
Listed
Listing
IPO 2001

Exact Sciences in the Madison ecosystem

Live from Dealroom

The Exact Sciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

Series B and later1 investor entered at this stage

  • Johns Hopkins University
Employees mapped 5,265 incl. 45 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 20 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$313M

121 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Exact Sciences was the backer or acquirer, 2017–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

55 deals across Exact Sciences's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where Exact Sciences deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        Exact Sciences's portfolio, mapped.

        Stage
        Period
        55 of 55 deals

        See Exact Sciences on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.